Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Surgery Partners (SGRY) Shares Issued (2021 - 2022)

Surgery Partners recorded quarterly Shares Issued of $882.9 million in Q4 2022, up 175.13% quarter-over-quarter from $320.9 million in Q4 2021, and up 175.13% year-over-year from $320.9 million in Q4 2021.

Surgery Partners' Shares Issued history runs 2 years deep, the most recent figure standing at $882.9 million for Q4 2022.

  • In Q4 2022, Shares Issued rose 175.13% year-over-year to $882.9 million; the TTM figure through Dec 2022 stood at $882.9 million (up 51.75% YoY), while the FY2022 annual figure was $882.9 million, up 51.75% from the prior year.
  • Shares Issued came in at $882.9 million for Q4 2022 at Surgery Partners, up from $320.9 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $882.9 million in Q4 2022 to a low of $260.9 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn -
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 2.39 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn -
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 11.49 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 3.78 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 1.31 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 Surgery Partners 1.71 Bn 1.92 Bn 590.70 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 882.90 Mn
Dec 31, 2022 882.90 Mn
Dec 31, 2021 320.90 Mn
Dec 31, 2021 320.90 Mn
Mar 31, 2021 260.90 Mn
Mar 31, 2021 260.90 Mn